High-avidity IgA protects the intestine by enchaining growing bacteria

  • Nature volume 544, pages 498502 (27 April 2017)
  • doi:10.1038/nature22058
  • Download Citation
Published online:


Vaccine-induced high-avidity IgA can protect against bacterial enteropathogens by directly neutralizing virulence factors or by poorly defined mechanisms that physically impede bacterial interactions with the gut tissues (‘immune exclusion’)1,2,3. IgA-mediated cross-linking clumps bacteria in the gut lumen and is critical for protection against infection by non-typhoidal Salmonella enterica subspecies enterica serovar Typhimurium (S. Typhimurium). However, classical agglutination, which was thought to drive this process, is efficient only at high pathogen densities (≥108 non-motile bacteria per gram). In typical infections, much lower densities4,5 (100–107 colony-forming units per gram) of rapidly dividing bacteria are present in the gut lumen. Here we show that a different physical process drives formation of clumps in vivo: IgA-mediated cross-linking enchains daughter cells, preventing their separation after division, and clumping is therefore dependent on growth. Enchained growth is effective at all realistic pathogen densities, and accelerates pathogen clearance from the gut lumen. Furthermore, IgA enchains plasmid-donor and -recipient clones into separate clumps, impeding conjugative plasmid transfer in vivo. Enchained growth is therefore a mechanism by which IgA can disarm and clear potentially invasive species from the intestinal lumen without requiring high pathogen densities, inflammation or bacterial killing. Furthermore, our results reveal an untapped potential for oral vaccines in combating the spread of antimicrobial resistance.

  • Subscribe to Nature for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    , & Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 4, 603–611 (2011)

  2. 2.

    New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 12, 821–832 (2012)

  3. 3.

    , & B cells as a critical node in the microbiota–host immune system network. Immunol. Rev. 260, 50–66 (2014)

  4. 4.

    WHO. Risk assessments of Salmonella in eggs and broiler chickens. (2002)

  5. 5.

    , & Shedding light on Salmonella carriers. Trends Microbiol. 20, 320–327 (2012)

  6. 6.

    Further Studies of the Salmonella Group. Great Britain Medical Research Council (Her Majesty’s Stationary Office) 103, 3–160 (1926)

  7. 7.

    & Kauffmann–White-Scheme (Behring Diagnostika, 1988)

  8. 8.

    et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog. 6, e1001097 (2010)

  9. 9.

    et al. Antibiotic-driven dysbiosis mediates intraluminal agglutination and alternative segregation of Enterococcus faecium from the intestinal epithelium. MBio 6, e01346e15 (2015)

  10. 10.

    , & Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology. Infect. Immun. 83, 1674–1683 (2015)

  11. 11.

    A mechanistic approach to plankton ecology. (Princeton Univ. Press, 2008)

  12. 12.

    & Persistent excretion of salmonellas. BMJ 2, 1301 (1978)

  13. 13.

    , & Inhibition of Salmonella enterica serovar Typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infect. Immun. 76, 4137–4144 (2008)

  14. 14.

    et al. Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. Infect. Immun. 80, 2454–2463 (2012)

  15. 15.

    , , & Exposure of Salmonella enterica serovar Typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclase-dependent pathway. Infect. Immun. 81, 653–664 (2013)

  16. 16.

    ., ., ., & Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect. Immun. 60, 1786–1792 (1992)

  17. 17.

    et al. Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology 107, 915–923 (1994)

  18. 18.

    et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839–2858 (2003)

  19. 19.

    , , & The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen’s virulence factors, and the host’s mucosal immune response. Immunol. Rev. 245, 56–83 (2012)

  20. 20.

    et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J. Immunol. 174, 1675–1685 (2005)

  21. 21.

    et al. Peracetic acid treatment generates potent inactivated oral vaccines from a broad range of culturable bacterial species. Front. Immunol. 7, 34 (2016)

  22. 22.

    , , , & Lymph node colonization dynamics after oral Salmonella typhimurium infection in mice. PLoS Pathog. 9, e1003532 (2013)

  23. 23.

    , , & Adaptive mutations in bacteria: high rate and small effects. Science 317, 813–815 (2007)

  24. 24.

    Methods in Molecular Biology. Horizontal Gene Transfer 532, 397–411 (2009)

  25. 25.

    et al. Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol. 6, e74 (2008)

  26. 26.

    et al. Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis. PLoS Pathog. 10, e1004557 (2014)

  27. 27.

    et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5, 2177–2189 (2007)

  28. 28.

    et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc. Natl Acad. Sci. USA 109, 1269–1274 (2012)

  29. 29.

    et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 6, e1000711 (2010)

  30. 30.

    et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000–1010 (2014)

  31. 31.

    et al. Salmonella gut invasion involves TTSS-2-dependent epithelial traversal, basolateral exit, and uptake by epithelium-sampling lamina propria phagocytes. Cell Host Microbe 11, 19–32 (2012)

  32. 32.

    et al. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J. Immunol. 162, 2521–2529 (1999)

  33. 33.

    et al. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 170, 2531–2539 (2003)

  34. 34.

    et al. Innate and adaptive immunity cooperate flexibly to maintain host–microbiota mutualism. Science 325, 617–620 (2009)

  35. 35.

    et al. Antibiotic treatment selects for cooperative virulence of Salmonella typhimurium. Curr. Biol. 24, 2000–2005 (2014)

  36. 36.

    & Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238–239 (1981)

  37. 37.

    et al. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe 14, 641–651 (2013)

  38. 38.

    et al. Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72, 4138–4150 (2004)

  39. 39.

    et al. O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect. Immun. 77, 2568–2575 (2009)

  40. 40.

    et al. Inflammation boosts bacteriophage transfer between Salmonella spp. Science 355, 1211–1215 (2017)

  41. 41.

    , & Some properties of five new Salmonella bacteriophages. J. Virol. 5, 754–764 (1970)

  42. 42.

    et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58, 1281–1289 (1990)

  43. 43.

    et al. Dynamic behavior of Salmonella-induced membrane tubules in epithelial cells. Traffic 9, 2117–2129 (2008)

  44. 44.

    & ColE1-type vectors with fully repressible replication. Gene 105, 17–22 (1991)

  45. 45.

    et al. Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry. Nat. Protocols 11, 1531–1553 (2016)

  46. 46.

    et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10, 871–875 (2004)

  47. 47.

    et al. Dynamics of intracellular bacterial replication at the single cell level. Proc. Natl Acad. Sci. USA 107, 3746–3751 (2010)

  48. 48.

    et al. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe 16, 237–248 (2014)

  49. 49.

    , , & ilastik: Interactive Learning and Segmentation Toolkit. Proc. Eighth IEEE International Symposium on Biomedical Imaging (ISBI). 2011, 230–233 (2011)

  50. 50.

    et al. Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol. 12, e1001793 (2014)

  51. 51.

    Random Walks in Biology (Princeton Univ. Press, 1993)

  52. 52.

    A model of the formation of marine algal flocs by physical coagulation processes. Deep-Sea Res. A, Oceanogr. Res. Pap. 37, 1197–1211 (1990)

  53. 53.

    , & Coagulation efficiency and aggregate formation in marine phytoplankton. Mar. Biol. 107, 235–245 (1990)

  54. 54.

    , , & Periodic fluid extrusion and models of digesta mixing in the intestine of a herbivore, the common brushtail possum (Trichosurus vulpecula). J. Comp. Physiol. B 175, 337–347 (2005)

Download references


The authors would like to acknowledge the support of ScopeM (ETHZ), and the staff at the RCHCI and EPIC animal facilities. They would also like to thank members of the Hardt and Hapfelmeier groups, as well as A. J. Macpherson, S. Sunagawa, M. F. Freeman, C. Mueller, B. Stecher, K. Endt, M. Stecher, M. Bajagic and M. Ackermann for technical help and/or their comments on the manuscript. E.S. is supported by the Swiss National Science Foundation (SNF, Marie Heim-Vöglin award PMPDP3_158364 and Ambizione award PZ00P3_136742 to E.S.). W.-D.H. is supported by the SNF (310030_53074; Sinergia CRSII_154414/1), ETH Zurich (ETH-33 12-2) and the Novartis Freenovation Programme. D.R.B. acknowledges support from a Human Frontier Science Program Cross-Disciplinary Fellowship. E.B. is supported by the Excellence Scholarship and Opportunity Programme (ETH). R.S. acknowledges support from a Gordon and Betty Moore Foundation Marine Microbial Initiative Award (GBMF 3783). R.R.R. acknowledges support from the Swiss National Science Foundation (31003A_149769). T.V. is supported by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (grant VO 2273/1-1) and M.E.S. by the Swedish Research Council (grants 2012-262 and 2015-00635).

Author information

Author notes

    • Kathrin Moor
    •  & Costanza Casiraghi

    Present addresses: Center for Dental Medicine, University of Zürich, Zürich, Switzerland (K.M.); Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy (C.C.).

    • Douglas R. Brumley
    • , Wolf-Dietrich Hardt
    •  & Emma Slack

    These authors contributed equally to this work.


  1. Institute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland

    • Kathrin Moor
    • , Médéric Diard
    • , Mikael E. Sellin
    • , Boas Felmy
    • , Sandra Y. Wotzka
    • , Albulena Toska
    • , Erik Bakkeren
    • , Markus Arnoldini
    • , Tom Völler
    • , Antonio Lanzavecchia
    • , Wolf-Dietrich Hardt
    •  & Emma Slack
  2. Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, 75124 Uppsala, Sweden

    • Mikael E. Sellin
  3. Laboratoire Jean Perrin (UMR 8237), CNRS - UPMC, 75005 Paris, France

    • Florence Bansept
    •  & Claude Loverdo
  4. Department of Environmental Systems Science, ETH Zurich, Zürich, Switzerland

    • Alma Dal Co
  5. Department of Environmental Microbiology, Eawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, Switzerland

    • Alma Dal Co
  6. Humabs BioMed SA, 6500 Bellinzona, Switzerland

    • Andrea Minola
    • , Gloria Agatic
    •  & Davide Corti
  7. Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona 6500, Switzerland

    • Blanca Fernandez-Rodriguez
    • , Sonia Barbieri
    • , Luca Piccoli
    • , Costanza Casiraghi
    •  & Antonio Lanzavecchia
  8. Institute of Integrative Biology, ETH Zürich, 8092 Zürich, Switzerland

    • Roland R. Regoes
  9. Institute of Environmental Engineering, Department of Civil, Environmental, and Geomatic Engineering, ETH Zürich, 8093 Zürich, Switzerland

    • Roman Stocker
    •  & Douglas R. Brumley
  10. School of Mathematics and Statistics, The University of Melbourne, Parkville, Victoria 3010, Australia

    • Douglas R. Brumley


  1. Search for Kathrin Moor in:

  2. Search for Médéric Diard in:

  3. Search for Mikael E. Sellin in:

  4. Search for Boas Felmy in:

  5. Search for Sandra Y. Wotzka in:

  6. Search for Albulena Toska in:

  7. Search for Erik Bakkeren in:

  8. Search for Markus Arnoldini in:

  9. Search for Florence Bansept in:

  10. Search for Alma Dal Co in:

  11. Search for Tom Völler in:

  12. Search for Andrea Minola in:

  13. Search for Blanca Fernandez-Rodriguez in:

  14. Search for Gloria Agatic in:

  15. Search for Sonia Barbieri in:

  16. Search for Luca Piccoli in:

  17. Search for Costanza Casiraghi in:

  18. Search for Davide Corti in:

  19. Search for Antonio Lanzavecchia in:

  20. Search for Roland R. Regoes in:

  21. Search for Claude Loverdo in:

  22. Search for Roman Stocker in:

  23. Search for Douglas R. Brumley in:

  24. Search for Wolf-Dietrich Hardt in:

  25. Search for Emma Slack in:


K.M., M.D., M.E.S., E.B., B.F., S.Y.W., A.T., W.-D.H and E.S. designed, performed and analysed experiments. M.A., A.D.C. and T.V. carried out image analysis. A.M., B.F.-R., G.A., S.B., L.P., C.C., D.C. and A.L. generated human monoclonal and mouse recombinant antibodies. F.B., C.L., and R.R.R. devised models and mathematically analysed barcoded-strain experiments. R.S. and D.R.B. devised and developed the model for planktonic bacteria population dynamics and wrote the extended discussion in the Supplementary Information. The paper was written by E.S. with support from W.-D.H. All authors discussed the results and commented on the manuscript.

Competing interests

The authors declare no competing financial interests.

Reviewer Information Nature thanks A. Baumler, A. Camilli, S. Fagarasan and A. Smith for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    This file contains a Supplementary Discussion and Supplementary Tables 1-2.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.